Indiana Medical Malpractice Guide: chart access, review timing, and where early mistakes cost the most

Indiana's Medical Malpractice Act (I.C. § 34-18-1-1 et seq.) — originally enacted in 1975 and significantly amended since — creates the most institutionally structured medical malpractice litigation system in the United States. Indiana is the only state to require, as a precondition to court litigation, that all medical malpractice claims first pass through a mandatory Medical Review Panel (MRP) process administered by the Indiana Department of Insurance (IDOI). No other state has maintained such a comprehensive pre-litigation panel review requirement that is also coupled with a two-tier damages cap enforced through a state-administered Patient Compensation Fund (PCF). Indiana's MMA has been challenged constitutionally multiple times. The Indiana Supreme Court upheld its constitutionality in Johnson v. St. Vincent Hospital, Inc., 273 Ind. 374, 404 N.E.2d 585 (1980), and has consistently reaffirmed that constitutionality through numerous subsequent challenges including Martin v. Richey, 674 N.E.2d 1015 (Ind. Ct. App. 1997) on the limitations period. Indiana's MMA creates a system fundamentally unlike anything in Massachusetts (which abolished its malpractice tribunal in 2012), Arizona (which has no equivalent pre-suit structure beyond certificate requirements), or Tennessee (which requires certificate of good faith but no review panel).

Indiana's major academic medical centers — Indiana University Health system (methodist hospital network), Ascension St. Vincent, Community Health Network, Eskenazi Health (formerly Wishard), and the Regenstrief Institute at IUPUI — operate within this structured environment. The presence of Indiana University School of Medicine in Indianapolis (one of the largest medical schools in the United States by enrollment, with nine campuses across Indiana) means a substantial portion of Indiana healthcare is delivered by residents, fellows, and academic physicians — all of whom are potential defendants in malpractice claims subject to the MMA's framework. Orthopedic care in the Warsaw-Kosciusko County area (home to the highest concentration of orthopedic device manufacturers in the world — Zimmer Biomet, DePuy Synthes, Biomet — headquartered nearby) creates a specialized context for product liability claims involving orthopedic implants that intersects with medical malpractice theory.

Patient Compensation Fund: Indiana's Unique Two-Tier Damages System

Indiana's PCF (I.C. § 34-18-6-1 et seq.) operates as follows: any qualified healthcare provider (who has complied with financial responsibility requirements — either purchasing qualifying malpractice insurance with minimum $250,000 per occurrence limits, or qualifying as a self-insurer) is subject to a liability cap of $400,000 per occurrence (as of legislation effective July 1, 2019, raised from prior cap of $250,000). For damages exceeding $400,000, the plaintiff's attorney submits a claim to the PCF for the excess, up to a total recovery (from all sources) capped at $1.8 million per occurrence (as of 2019, increased from $1.25 million). The PCF is funded by mandatory annual surcharges on qualified healthcare providers — Indiana doctors, hospitals, and other providers pay into the PCF based on their specialty and type. Surgical specialists pay higher surcharges than primary care physicians. The practical consequence: Indiana patients with catastrophic malpractice injuries (wrongful death of a breadwinner, permanent disability requiring lifetime care) face a maximum recovery of $1.8 million from all sources combined, regardless of the actual economic damages (lifetime medical care costs for a severely brain-injured infant, for example, can easily exceed $10-20 million). Indiana's cap is lower than most states' medical malpractice caps because Indiana's PCF provides an additional funding layer beyond the provider cap.